Biomarker research may revolutionize early detection of colorectal cancer
A large-scale research project, jointly carried out by the Austrian biotech company BIOCRATES Life Sciences and the Vienna Institute for Cancer Research and combining technologies from the fields of genomics, proteomics, and metabolomics, aims at optimizing the early detection of and treatment monitoring for colorectal cancer. Read more
